MOMENTAN AUSVERKAUFT

McGraw Hill's 2024/2025 Top 300 Pharmacy Drug Cards by Jill M. Kolesar and Lee C. Vermeulen (2023, Book, Other)

Über dieses Produkt

Product Identifiers

PublisherMcGraw-Hill Medical Publishing Division
ISBN-101264277849
ISBN-139781264277841
eBay Product ID (ePID)3062159093

Product Key Features

Number of Pages608 Pages
Publication NameMcgraw Hill's 2024/2025 Top 300 Pharmacy Drug Cards
LanguageEnglish
SubjectPharmacology
Publication Year2023
TypeTextbook
AuthorJill M. Kolesar, Lee C. Vermeulen
Subject AreaMedical
FormatBook, Other

Dimensions

Item Weight63.3 Oz

Additional Product Features

Edition Number7
Intended AudienceScholarly & Professional
IllustratedYes
SynopsisThe quickest, most efficient way to master critical facts about common drugs Perfect for NAPLEX and course review, McGraw Hill's 2024/2025 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. Adverse reactions are organized by common, less common, and rare but serious to help users organize thoughts for counseling patients. This updated edition includes 30 new cards. Each card features: - Generic and common name - Dosage Forms - Approved Dose and Indications - Off-Label Use - Contraindications - Adverse Reactions - Drug Interactions - Monitoring Parameters - Medication Safety Issues and Black Box Warnings - Strong focus on patient safety, The quickest, most efficient way to master critical facts about common drugs Perfect for NAPLEX and course review, McGraw Hill's 2024/2025 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. Adverse reactions are organized by common, less common, and rare but serious to help users organize thoughts for counseling patients. This updated edition includes 30 new cards. Each card features: * Generic and common name * Dosage Forms * Approved Dose and Indications * Off-Label Use * Contraindications * Adverse Reactions * Drug Interactions * Monitoring Parameters * Medication Safety Issues and Black Box Warnings * Strong focus on patient safety